Equities Analysts Offer Predictions for ACRS Q2 Earnings
Aclaris Therapeutics, Inc. (NASDAQ:ACRS – Free Report) – Equities research analysts at Wedbush issued their Q2 2025 EPS estimates for shares of Aclaris Therapeutics in a research note issued to investors on Wednesday, May 28th. Wedbush analyst M. Fan expects that the biotechnology company will post earnings of ($0.12) per share for the quarter. Wedbush […]
Aclaris Therapeutics, Inc. (NASDAQ:ACRS – Free Report) – Equities research analysts at Wedbush issued their Q2 2025 EPS estimates for shares of Aclaris Therapeutics in a research note issued to investors on Wednesday, May 28th. Wedbush analyst M. Fan expects that the biotechnology company will post earnings of ($0.12) per share for the quarter. Wedbush […]
